Adaptimmune Therapeutics Plc - ADR
ADAP
Market Cap$65.24M
Close$
$2.33
862.2% upside
Current Fair Value
862.2% upsideUndervalued by 862.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $65.24 Million |
|---|---|
| Enterprise Value | $65.62 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.28 |
| Beta | 2.26 |
| Outstanding Shares | 257,026,603 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.93 |
|---|---|
| PEG | 49.1 |
| Price to Sales | - |
| Price to Book Ratio | -0.24 |
| Enterprise Value to Revenue | 0.37 |
| Enterprise Value to EBIT | -1.01 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.63 |
| Debt to Equity | -1.11 |
Revenue Sources
No data
Insider Trades
ESG Score
No data